Deletion of the 5′ abl region in Philadelphia chromosome-positive chronic myeloid leukemia [8]

Leukemia

Volumn 17, Issue 2, 2003, Pages 473-474

  Morel, F ^a,b   Ka, C ^a,b   Le Bris, M J ^a   Herry, A ^a,b   Morice, P ^c   Bourquard, P ^c   Abgrall, J F ^b,d   Berthou, C ^b,d   De Braekeleer, M ^a,b  

^a BREST UNIVERSITY HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^c Centre Hospitalier La Beauchee   (France)

^d CHU MORVAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 14; CHROMOSOME TRANSLOCATION 16; CHROMOSOME TRANSLOCATION 17; CHROMOSOME TRANSLOCATION 2; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 3; CHROMOSOME TRANSLOCATION 4; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE CLUSTER; GENE DELETION; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; KARYOTYPING; LETTER; MAJOR CLINICAL STUDY; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; CHROMOSOME DELETION; GENE FREQUENCY; GENE TRANSLOCATION; GENETIC VARIABILITY; GENETICS; MYELOID LEUKEMIA; ONCOGENE; RETROSPECTIVE STUDY;

CHROMOSOME DELETION; FUSION PROTEINS, BCR-ABL; GENE FREQUENCY; GENES, ABL; HUMANS; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; PHILADELPHIA CHROMOSOME; RETROSPECTIVE STUDIES; TRANSLOCATION, GENETIC; VARIATION (GENETICS);

EID: 0037289758     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2402816     Document Type: Letter

References (12)

1. Huntly BJP, Reid AG, Bench AJ, Campbell LJ, Telford N, Shepherd P, Szer J, Prince HM, Turner P, Grace C, Nacheva EP, Green AR. Deletions of the derivative chromosome 9 occur at the time of the Philadelphia translocation and provide a powerful and independent prognostic indicator in chronic myeloid leukemia. Blood 2001; 98: 1732-1738.
2. Kolomietz E, Al-Maghrabi J, Brennan S, Karaskova J, Minkin S, Lipton J, Squire JA. Primary chromosomal rearrangements of leukemia are frequently accompanied by extensive submicroscopic deletions and may lead to altered prognosis. Blood 2001; 97: 3581-3588.
3. Calabrese G, Stuppia L, Guanciali Franchi P, Peila R, Morizio E, Liberati AM, Spadano A, Di Lorenzo R, Donti E, Antonucci A, Palka G. Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis. Cancer Genet Cytogenet 1994; 78: 153-159.
4. Dewald GW, Wyatt WA, Silver RT. Atypical BCR and ABL D-FISH patterns in chronic myeloid leukemia and their possible role in therapy. Leuk Lymphoma 1999; 34: 481-491.
5. Grand F, Kulkarni S, Chase A, Goldman JM, Gordon M, Cross NCP. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Cancer Res 1999; 59: 3870-3874.
6. Le Gouill S, Talmant P, Milpied N, Daviet A, Ancelot M, Moreau P, Harousseau JL, Bataille R, Avet-Loiseau H. Fluorescence in situ hybridization on peripheral blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia. J Clin Oncol 2000; 18: 1533-1538.
7. Sinclair PB, Nacheva EP, Leversha M, Telford N, Chang J, Reid A, Bench A, Champion K, Huntly B, Green AR. Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia. Blood 2000; 95: 738-744.
8. Herens C, Tassin F, Lemaire V, Beguin Y, Collard E, Lampertz S, Croisiau C, Lecomte M, De Prijk B, Longrée L, Koulischer L. Deletion of the 5′-ABL region: a recurrent anomaly detected by fluorescence in situ hybridization in about 10% of Philadelphia-positive chronic myeloid leukaemia patients. Br J Haematol 2000; 110: 214-216.
9. Markovic VD, Bouman D, Bayani J, Al-Maghrabi J, Kamel-Reid S, Squire JA. Lack of BCR/ABL reciprocal fusion in variant Philadelphia chromosome translocations: a use of double fusion signal FISH and spectral karyotyping. Leukemia 2000; 14: 1160.
10. Mohr B, Bornhauser M, Platzbecker U, Freiberg-Richter J, Naumann R, Prange-Krex G, Mohm J, Kroschinsky F, Ehninger G, Thiede C. Problems with interphase fluorescence in situ hybridization in detecting BCR/ABL-positive cells in some patients using a novel technique with extra signals. Cancer Genet Cytogenet 2001; 127: 111-117.
11. Cohen N, Rozenfeld-Granot G, Hardan I, Brok-Simoni F, Amariglio N, Rechavi G, Trakhtenbrot L. Subgroup of patients with Philadelphia-positive chronic myelogenous leukemia characterized by a deletion of 9q proximal to ABL gene: expression profiling, resistance to interferon therapy, and poor prognosis. Cancer Genet Cytogenet 2001; 128: 114-119.
12. Gonzalez FA, Anguita E, Mora A, Asenjo S, Lopez I, Polo M, Villegas A. Deletion of BCR region 3′ in chronic myelogenous leukemia. Cancer Genet Cytogenet 2001; 130: 68-74.